Alivus Life Sciences Limited has issued notice for its 15th Annual General Meeting (AGM) scheduled to be held on Tuesday, September 8, 2026 at 3:00 PM IST through Video Conferencing (VC)/Other Audio-Visual Means (OAVM). The meeting will transact both ordinary and special business.

Ordinary Business Items:

1. Approval of Financial Statements: To receive, consider, approve and adopt the Audited Financial Statements for the Financial Year ended March 31, 2026 together with reports of the Board and Auditors.

2. Declaration of Final Dividend: To declare a final dividend of ₹5 (Rupees Five only) per equity share of face value ₹2 each fully paid up for the financial year ended March 31, 2026.

3. Re-appointment of Director: To appoint Mr. Hiren Patel (DIN: 00145149), aged 53 years, as Non-Executive Director who retires by rotation and is eligible for re-appointment under Section 152(6) of the Companies Act, 2013.

Special Business Item:

4. Ratification of Cost Auditor Remuneration: To ratify remuneration of ₹0.50 million plus applicable taxes and reimbursement of actual travel and out-of-pocket expenses to Kirit Mehta & Co. LLP, Cost Auditors of the Company for conducting audit of company's cost records for financial year ending March 31, 2027.

Meeting Logistics:

  • The AGM will be held entirely through electronic mode (VC/OAVM) without physical attendance
  • Remote e-voting facility will be available through NSDL e-Voting system from Friday, September 4, 2026 (9:00 AM IST) to Monday, September 7, 2026 (5:00 PM IST)
  • Cut-off date for determining voting eligibility is Tuesday, September 1, 2026
  • Record date for dividend entitlement is Tuesday, September 1, 2026
  • Dividend payment, if approved, will be made on or after Friday, September 11, 2026

Director Information (Mr. Hiren Patel):

  • Original Date of Appointment: March 6, 2024
  • Qualification: Bachelor's degree in Engineering from Stevens Institute of Technology, USA and Master's Degree in Business Administration from Drexel University, USA
  • Experience: Chairman and Non-Executive Director with experience in consumer goods, chemicals, cement, and healthcare industry
  • Board Meeting Attendance: 3 out of 4 meetings in FY 2025-26
  • Shareholding: Nil
  • Holds directorships in 6 other companies including Nirma Limited and Nuvoco Vistas Corporation Limited

Additional Information:

  • The company has appointed Mr. Bhadresh Shah, Practicing Company Secretary, as Scrutinizer for e-voting process
  • Members can request physical copies of Integrated Annual Report 2025-26 by emailing complianceofficer@alivus.com
  • Entire share capital of the company is held in dematerialized form
  • NACH facility is available for dividend remittance to avoid loss of dividend warrants in transit
  • Detailed TDS provisions are provided for resident and non-resident shareholders on dividend income